FGFR1 underlies obesity-associated progression of estrogen receptor–positive breast cancer after estrogen deprivation

Obesity increases breast cancer mortality by promoting resistance to therapy. Here, we identified regulatory pathways in estrogen receptor–positive (ER-positive) tumors that were shared between patients with obesity and those with resistance to neoadjuvant aromatase inhibition. Among these was fibro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JCI Insight
Main Authors: Wellberg, Elizabeth A., Kabos, Peter, Gillen, Austin E., Jacobsen, Britta M., Brechbuhl, Heather M., Johnson, Stevi J., Rudolph, Michael C., Edgerton, Susan M., Thor, Ann D., Anderson, Steven M., Elias, Anthony, Zhou, Xi Kathy, Iyengar, Neil M., Morrow, Monica, Falcone, Domenick J., El-Hely, Omar, Dannenberg, Andrew J., Sartorius, Carol A., MacLean, Paul S.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Clinical Investigation 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6124402/
https://ncbi.nlm.nih.gov/pubmed/30046001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.120594
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares